71例肝脓肿临床及病原学特点分析

来源期刊：广州医药 | 55-59 发布时间：2021-11-23 收稿时间：2025/11/13 18:05:24 阅读量：13

作者：: 付喜花,

毛玉巧,

关键词：: 肝脓肿病原学肺炎克雷伯菌; Bacterial liver abscess Etiology Klebsiella pneumoniae

DOI：: 10.3969/j.issn.1000-8535.2021.04.012

收稿时间：
修订日期：
接收日期：
引用总数：: 0

目的分析肝脓肿的临床基线及病原学特征,旨在提高临床对该病早期识别、病原体预判、并发症警惕及抗感染治疗能力。方法收集广州番禺区中心医院2019年1月—2020年11月收治的肝脓肿病例相关临床及实验室资料。按病原体培养结果分成阳性组、阴性组。阳性组中,按不同致病菌分成肺炎克雷伯及非肺炎克雷伯亚组。比较不同组别间基线特征及实验室数据。结果共收集肝脓肿71例,病原学培养阳性率83.1%(59例),其中肺炎克雷伯菌46例(80%)。最常见合并症包括糖尿病(54.9%)、胆道疾病(56.3%)、肺部感染(67.6%)等。病原体阳性组PCT和AST水平高于阴性组(P<0.05),但是两组之间基线特征无差异(P>0.05)。肺炎克雷伯亚组与其他病原体组相比,合并糖尿病的风险更高(P=0.007),PLT、PCT、ALT、AST和白蛋白的水平具有显著差异(P <0.05)。经过积极治疗,大多预后良好,未见死亡病例,其中7例患者发生严重侵袭性脓肿,遗留后遗症。结论病原体阴性肝脓肿致病力方面与阳性组并无差别。肺炎克雷伯杆菌已成为肝脓肿中最常见菌群,其多见于合并糖尿病患者。其PLT、PCT、ALT、AST指标明显高于其他菌群组,伴白蛋白消耗明显。少数可伴有全身严重侵袭性脓肿。

1、 MAVILIA M G, MOLINA M, WU G Y. The evolving nature of hepatic abscess: a review[J]. J Clin Transl Hepatol,2016,4(2):158-168.

2、 HOPE W W, VROCHIDES D V, NEWCOMB W L, et al. Optimal treatment of hepatic abscess[J]. Am Surg,2008,74(2):178-182.

3、 FANG C T, LAI S Y, YI W C,et al.Klebsiella pneumoniae genotype K1: an emerging pathogen that causes septic ocular or central nervous system complications from pyogenic liver abscess[J]. Clin Infect Dis,2007,45(3):284-293.

4、 LEE J Y, KIM K H.Endogenous endophthalmitis complicated by pyogenic liver abscess: a review of 17 years' experience at asingle center[J]. Digestion,2014, 90(2):116-121.

5、 CHEN S C, LEE Y T, LAI K C,et al. Risk factors for developing metastatic infection from pyogenic liver abscesses[J]. Swiss Med Wkly,2006, 136(7-8):119-126.

6、 ZUO H, SHI Z, HUSSAIN A . Prevalence, trends and riskfactors for the diabetes epidemic in China: a systematic review and metaanalysis[J]. Diabetes Res Clin Pract,2014,104(1):63-72.

7、 CHEN S C, YEN C H, TSAO S M,et al. Comparison of pyogenic liver abscesses of biliary and cryptogenic origin. An eight-year analysis in a university hospital[J].Swiss Med Wkly,2005,135(23-24):344-351.

8、 LUO M,YANG X X,TAN B,et al.Distribution of common pathogens in patients with pyogenic liver abscess in China: a meta-analysis[J].Eur J Clin Microbiol Infect Dis,2016,35(10):1557-1565.

9、 JUN J B.Klebsiella pneumoniae liver abscess[J].Infect Chemother, 2018,50(3):210-218.

10、 CHEMALY R F, HALL G S, KEYS T F, et al. Microbiology of liver abscesses and the predictive value of abscess gram stain and associated blood cultures[J]. Diagn Microbiol Infect Dis,2003,46(4):245-248.

11、 NAH B K, KIM Y S, MOON H S, et al. Recent changes of organism and treatment in pyogenic liver abscess[J]. Taehan Kan Hakhoe Chi, 2003,9(4):275-283.

12、 CORREDOIRA SANCHEZ J C, CASARIEGO VALES E, IBANEZ ALONSO M D, et al. Pyogenic liver abscess: changes in etiology, diagnosis and treatment over 18 years[J]. Rev Clin Esp,1999,199(11):705-710.

13、 LEDERMAN E R, CRUM N F. Klebsiella liver abscess: a coast-to-coast phenomenon[J]. Clin Infect Dis,2005,41(2):273.

14、 LEDERMAN E R, CRUM N E. Pyogenic liver abscess with a focus on Klebsiella pneumoniae as a primary pathogen: an emerging disease with unique clinical characteristics[J].Am J Gastroenterol, 2005,100(2):322-331.

15、 SEETO R K, ROCKEY D C. Pyogenic liver abscess. Changes in etiology, management, and outcome[J]. Medicine (Baltimore),1996,75(2):99-113.

16、 KAPLAN G G, GREGSON D B, LAUPLAND K B, et al. Population-based study of the epidemiology of and the risk factors for pyogenic liver abscess[J]. Clin Gastroenterol Hepatol,2004,2(11):1032-1038.

17、 TSAI F C, HUANG Y T, CHANG L Y, et al. Pyogenic liver abscess as endemic disease, Taiwan[J]. Emerg Infect Dis,2008,14(10):1592-600.

18、 MEDDINGS L, MYERS R P, HUBBARD J, et al. A population-based study of pyogenic liver abscesses in the United States: incidence, mortality, and temporal trends[J]. Am J Gastroenterol,2010,105(1):117-124.